FDA
FDA Articles
Geron is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel again like the Geron that everyone knew before.
Published:
Shares of Dendreon moved higher Monday after the biotech company said it will start to market Provenge, its prostate-cancer drug, in Europe this year. Its fourth-quarter loss was smaller than...
Published:
Shares of biotechnology company Anika Therapeutics soared to an all-time high Wednesday after the company said the FDA had approved its drug to treat pain and improve joint mobility in patients with...
Published:
Chelsea Therapeutics is finding a serious victory from its hypotension drug. Shares hit a multiyear high after it confirmed an accelerated FDA approval of its Northera for the treatment of low blood...
Published:
ThinkstockMannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company’s inhalable insulin has been held up from being approved for years as well. That seems to...
Published:
Jon OggDendreon Corp. (NASDAQ: DNDN) is by almost all measurements nothing short of a total failure of a biotech or biohealth stock. Despite having a solid prostate cancer treatment in Provenge,...
Published:
ThinkstockBiotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn exponential rewards if they are right, or they can lose it...
Published:
ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the possibility of an inhalable form of insulin ultimately being approved by the Food...
Published:
Jon OggInvesting in biotech and emerging pharmaceutical stocks comes with a huge risk and reward profile for investors. Some wins are exponential, yet some losses are losses of the entire investment....
Published:
via Wikimedia CommonsAriad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that the...
Published:
ThinkstockA malaria vaccine is supposed to be a good thing. Right? Unfortunately that all depends. GlaxoSmithKline PLC (NYSE: GSK) currently plans to seek marketing approval for the first malaria...
Published:
ThinkstockEnteroMedics Inc. (NASDAQ: ETRM) may be a largely unknown microcap stock to most investors. The company is in the development stages of making medical devices using neuroblocking technology...
Published:
via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is that some...
Published:
ThinkstockNektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for pain management and for cancer, and now its investigational drug...
Published:
ThinkstockJohnson & Johnson (NYSE: JNJ) has been one of the great health care and consumer products survivors of our lifetimes. Even the latest round of over-the-counter quality control flaws did...
Published: